TWiV reviews measles in Kenya, a trial for a intranasal COVID vaccine, dengue in the Florida Keys and in Central/South America, Spain connecting government with scientists, T cell activation and viral RNA fragments persist for up to 2 years after SARS-CoV-2 infection, and durable cross-reactive and protective antibodies against avian N2 neuraminidases elicited by A(H2N2) and A(H3N2) influenza pandemics.
Hosts: Vincent Racaniello and Alan Dove
Click arrow to play
Download TWiV 1129 (75 MB .mp3, 104 min)
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- MicrobeTV Discord Server
- Measles in Kenya (WHO) 2:29
- Intranasal COVID vaccine trial (NIH) 3:49
- Dengue in Florida Keys (Florida Health) 6:00
- Dengue rising in Central/South America (NPR) 7:40
- Spain to connect scientists with government (Science) 8:36
- Persistence of T cells and viral RNA after SARS-CoV-2 infection (Sci Transl Med) 11:29
- Influenza pandemics induce cross-reactive antibodies against avian N2 (Nat Comm) 36:41
- Letters read on TWiV 1129 1:07:29
- Timestamps by Jolene. Thanks!
Weekly Picks 1:37:59
Alan – The first few minutes of this video by Roger Barnes
Vincent – Billy & Molly: An Otter Love Story
Listener Picks
Fernando – A City on Mars
Intro music is by Ronald Jenkees
Send your virology questions and comments to twiv@microbe.tv
Content in this podcast should not be construed as medical advice.
Leave a Reply